Codabakalner: Clinical Trials

1 trial of Codabakalner, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Not yet recruiting 1
Phase 31Not yet recruiting 1

Follow Codabakalner: new trials by email Literature Review of Codabakalner trials Research Report on Codabakalner

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Investigate the Effects and Safety of Codabakalner for the Treatment of FXS in Male Participants and Adult Participants With ADS
Codabakalner, Placebo - Fragile X Syndrome (FXS), Autism Spectrum Disorder (ASD)
Phase 2 / Phase 3Not yet recruitingSpinogenix1202026-12-012026-10-09

Conditions studied

Autism Spectrum Disorder (1)  ·  Autistic Disorder (1)  ·  Fragile X Syndrome (1)

Sponsors

Spinogenix (1)